| Malignant risk stratification of thyroid FNA specimens with indeterminate cytology based on molecular testing S Paskaš, J Janković, V Živaljević, S Tatić, V Božić, A Nikolić, ... Cancer cytopathology 123 (8), 471-479, 2015 | 37 | 2015 |
| Evaluation of survivin expression and its prognostic value in papillary thyroid carcinoma S Selemetjev, TI Dencic, I Marecko, J Jankovic, I Paunovic, S Savin, ... Pathology-Research and Practice 210 (1), 30-34, 2014 | 24 | 2014 |
| MMP-9-1562 C/T single nucleotide polymorphism associates with increased MMP-9 level and activity during papillary thyroid carcinoma progression J Roncevic, I Djoric, S Selemetjev, J Jankovic, TI Dencic, V Bozic, ... Pathology 51 (1), 55-61, 2019 | 21 | 2019 |
| Inverse expression of caveolin-1 and EGFR in thyroid cancer patients J Janković, S Tatić, V Božić, V Živaljević, D Cvejić, S Paskaš Human pathology 61, 164-172, 2017 | 18 | 2017 |
| Caveolin-1 expression in papillary thyroid carcinoma: correlation with clinicopathological parameters and BRAF mutation status S Paskaš, J Janković, I Marečko, T Išić Denčić, S Tatić, D Cvejić, S Savin Otolaryngology--Head and Neck Surgery 150 (2), 201-209, 2014 | 15 | 2014 |
| Focal adhesion kinase splicing and protein activation in papillary thyroid carcinoma progression VB Ignjatović, JR Janković Miljuš, JV Rončević, SB Tatić, TM Išić Denčić, ... Histochemistry and Cell Biology 157 (2), 183-194, 2022 | 9 | 2022 |
| Predictive Significance of Two MMP-9 Promoter Polymorphisms and Acetylated c-Jun Transcription Factor for Papillary Thyroid Carcinoma Advancement J Rončević, J Janković Miljuš, T Išić Denčić, V Božić, V Živaljević, ... Diagnostics 12 (8), 1953, 2022 | 6 | 2022 |
| Elevated BANCR expression levels have different effects on papillary thyroid carcinoma progression depending on the presence of the BRAFV600E mutation S Stojanović, S Šelemetjev, I Đorić, J Rončević, JJ Miljuš, V Živaljević, ... European Journal of Surgical Oncology 46 (10), 1835-1842, 2020 | 6 | 2020 |
| Caveolin-1 expression in thyroid neoplasia spectrum: Comparison of two commercial antibodies J Janković, S Paskaš, I Marečko, V Božić, D Cvejić, S Savin Disease markers 33 (6), 321-331, 2012 | 5 | 2012 |
| MiR-203a-3p, miR-204-3p, miR-222-3p as useful diagnostic and prognostic tool for thyroid neoplasia spectrum S Stojanović, Z Dobrijević, S Šelemetjev, I Đorić, J Janković Miljuš, ... Endocrine, 1-15, 2022 | 4 | 2022 |
| Circulating MicroRNA Profiles as Potential Biomarkers for differentiated thyroid cancer recurrence J Jankovic Miljus, MA Guillén-Sacoto, J Makiadi-Alvarado, L Wert-Lamas, ... The Journal of Clinical Endocrinology & Metabolism 107 (5), 1280-1293, 2022 | 2 | 2022 |
| Coexistence of BRAFV600E mutation and EGFR overexpression is highly associated with adverse clinicopathological features of papillary thyroid carcinoma I Paunović, S Šelemetjev, TI Denčić, I Đorić, JJ Miljuš, J Rončević, ... Archives of Biological Sciences 72 (1), 37-44, 2020 | 1 | 2020 |
| Profiling circulating microRNAs as serum biomarkers for thyroid cancer recurrence before and after recombinant human TSH stimulation J Jankovic-Miljus, L Wert-Lamas, MA Guillen-Sacoto, A Martinez-Cano, ... Endocrine Abstracts 63, 2019 | 1 | 2019 |
| Detecting thyrotropin receptor mRNA from peripheral blood of patients with differentiated thyroid cancer rules out non-aggressive cases JR Janković Miljuš, U Prosenc Zmrzljak, R Košir, M Jovanović, IĐ Đorić, ... Annals of Clinical Biochemistry, 00045632241228217, 2024 | | 2024 |
| Detecting thyrotropin receptor mRNA from peripheral blood of patients with differentiated thyroid cancer rules out non-aggressive cases JRJ Miljuš, UP Zmrzljak, M Jovanović, IĐ Đorić, JV Rončević, TMI Denčić, ... Annals of clinical biochemistry, 45632241228217, 2024 | | 2024 |
| BRAFV600E, BANCR, miR-203a-3p and miR-204-3p in Risk Stratification of PTC Patients S Stojanović, S Šelemetjev, I Đorić, J Janković Miljuš, S Tatić, V Živaljević, ... Biomedicines 11 (12), 3338, 2023 | | 2023 |
| Expression of pY397-FAK and Its miR Regulators Drive Dedifferentiation in the Thyroid Neoplasia Spectrum V Ignjatović Jocić, J Janković Miljuš, T Išić Denčić, V Živaljević, S Tatić, ... Cells 12 (13), 1721, 2023 | | 2023 |
| Down-regulated HSA-MIR-204-3p may identify high-risk papillary thyroid carcinoma patients S Stojanović, S Selemetjev, I Đorić, J Jankovic, V Živaljević, S Tatić, ... Endocrine Abstracts 84, 2022 | | 2022 |
| Analiza proteinskih i genetičkih biomarkera u preoperativnoj i postoperativnoj diferencijalnoj dijagnostici tumora štitaste žlezde JR Janković Univerzitet u Beogradu-Hemijski fakultet, 2016 | | 2016 |
| Immunohistochemical analysis of caveolin-1 in follicular cell derived thyroid gland tumours J Jankovic, I Marecko, S Tatic, V Bozic, D Cvejic, S Savin FEBS JOURNAL 279, 106-106, 2012 | | 2012 |
